D. Cianniello and R. Caputo, “Patient with metastatic breast cancer, HER2-positive, trastuzumab- and pertuzumab-resistant responding to lapatinib: Paziente con carcinoma mammario metastatico, HER2-positivo, resistente a trastuzumab e pertuzumab ma responsivo a lapatinib”, AboutOpen, vol. 4, no. 1, pp. 66–68, Jun. 2018.